See more : GSRX Industries Inc. (GSRX) Income Statement Analysis – Financial Results
Complete financial analysis of Columbia Care Inc. (CCHW.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Columbia Care Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Clinigen Group plc (CLIN.L) Income Statement Analysis – Financial Results
- Fiji Kava Limited (FIJ.AX) Income Statement Analysis – Financial Results
- EFOR CAY SANAYI (EFORC.IS) Income Statement Analysis – Financial Results
- JK Holdings Co., Ltd. (9896.T) Income Statement Analysis – Financial Results
- Amarjothi Spinning Mills Limited (AMARJOTHI.BO) Income Statement Analysis – Financial Results
Columbia Care Inc. (CCHW.CN)
About Columbia Care Inc.
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 511.58M | 460.08M | 179.50M | 77.46M |
| Cost of Revenue | 310.37M | 266.07M | 113.53M | 40.60M |
| Gross Profit | 201.21M | 194.02M | 65.98M | 36.86M |
| Gross Profit Ratio | 39.33% | 42.17% | 36.76% | 47.59% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 203.69M | 179.48M | 118.34M | 105.44M |
| Selling & Marketing | 14.17M | 16.26M | 6.08M | 5.79M |
| SG&A | 617.45M | 195.73M | 124.42M | 111.24M |
| Other Expenses | -16.45M | 36.32M | 15.65M | 7.45M |
| Operating Expenses | 617.45M | 232.05M | 140.07M | 118.68M |
| Cost & Expenses | 927.82M | 498.12M | 253.60M | 159.28M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 53.90M | 30.01M | 0.00 | 0.00 |
| Depreciation & Amortization | 84.79M | 53.00M | 42.02M | 26.26M |
| EBITDA | -416.24M | 13.64M | -32.08M | -55.56M |
| EBITDA Ratio | -81.36% | 2.96% | -17.87% | -71.73% |
| Operating Income | -416.24M | -39.37M | -74.10M | -81.82M |
| Operating Income Ratio | -81.36% | -8.56% | -41.28% | -105.63% |
| Total Other Income/Expenses | -16.45M | -107.35M | -62.77M | -12.04M |
| Income Before Tax | -432.69M | -146.71M | -136.87M | -93.85M |
| Income Before Tax Ratio | -84.58% | -31.89% | -76.25% | -121.17% |
| Income Tax Expense | -11.21M | 139.00K | -3.67M | 12.87M |
| Net Income | -421.48M | -146.85M | -133.20M | -106.73M |
| Net Income Ratio | -82.39% | -31.92% | -74.20% | -137.79% |
| EPS | -1.07 | -0.43 | -0.57 | -0.51 |
| EPS Diluted | -1.07 | -0.43 | -0.57 | -0.51 |
| Weighted Avg Shares Out | 392.57M | 338.75M | 232.58M | 209.99M |
| Weighted Avg Shares Out (Dil) | 392.57M | 338.75M | 232.58M | 209.99M |
Source: https://incomestatements.info
Category: Stock Reports